Companies & Industry »Company News»Company News Details
Company News Details

BSE   07 Jul 15 | 12:29 PM

1847.25 14.15 (0.77%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   07 Jul 15 | 12:19 PM

1845.00 15.45 (0.84%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 1,796.90 (2.80%)
1 Month : Rs 1,798.95 (2.68%)
1 Year : Rs 1,154.40 (60.02%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Sensex

Company Price Gain (%)
Coal India428.251.98
H D F C1,342.701.88
Wipro558.051.50
Sun Pharma.Inds.887.600.98
M & M1,331.400.81

Online Portfolio

You can create Online Portfolio here using the below button.